Sign In
Buy ALKS
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026
Why Alkermes (ALKS) Might Surprise This Earnings Season
12:41pm, Tuesday, 28'th Jul 2020
Alkermes (ALKS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Alkermes to Host Conference Call to Discuss Second Quarter 2020 Financial Results
08:00pm, Wednesday, 22'nd Jul 2020
Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, July 29, 2020 to discuss the company's second quarter 2020 financial resu
Alkermes (ALKS) Expected to Beat Earnings Estimates: Should You Buy?
04:32pm, Thursday, 16'th Jul 2020
Alkermes (ALKS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Did Hedge Funds Make The Right Call On Alkermes Plc (ALKS) ?
02:32pm, Monday, 13'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?
01:36pm, Tuesday, 30'th Jun 2020
Investors need to pay close attention to Alkermes (ALKS) stock based on the movements in the options market lately.
Alkermes Announces Launch of 3rd Annual Alkermes Pathways Research Awards® Program
11:00am, Monday, 29'th Jun 2020
Alkermes plc (Nasdaq: ALKS) today announced that it will begin accepting applications for its annual Alkermes Pathways Research Awards® program on July 1, 2020. This competitive grant program is desi
Alkermes Awards COVID-19 Relief Fund Grants to 10 Innovative Programs Designed to Address Challenges for Patient Communities
11:00am, Wednesday, 24'th Jun 2020
Alkermes plc (Nasdaq: ALKS) today announced that 10 nonprofit organizations have been awarded grants from the company's COVID-19 Relief Fund, a special edition of the company's signature Alkermes Insp
Alkermes plc (Nasdaq: ALKS) and Clovis Oncology, Inc. (Nasdaq: CLVS) today announced positive preclinical data from a study designed to evaluate the combination potential of ALKS 4230, Alkermes' inves
Alzheimer's Drug Approval More Critical for Biogen After Patent Decision
10:04pm, Friday, 19'th Jun 2020
Piper analyst considers OK a longshot and another reason not to be bullish on stock Continue reading...
Should You Avoid Alkermes Plc (ALKS)?
01:11pm, Friday, 12'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
How Alkermes (ALKS) Stock Stands Out in a Strong Industry
01:04pm, Monday, 08'th Jun 2020
Alkermes (ALKS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Alkermes to Take Part in 41st Annual Goldman Sachs Global Healthcare Conference
08:00pm, Thursday, 04'th Jun 2020
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 41st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2020 at 9:40 a.m. ET
Alkermes (ALKS) Up 21.6% Since Last Earnings Report: Can It Continue?
03:31pm, Friday, 29'th May 2020
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alkermes To Highlight New Data From Schizophrenia Portfolio At The American Society Of Clinical Psychopharmacology 2020 Annual Meeting
11:10am, Wednesday, 27'th May 2020Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting
11:00am, Wednesday, 27'th May 2020
Alkermes plc (Nasdaq: ALKS) today announced plans to present new research from its schizophrenia portfolio at the American Society of Clinical Psychopharmacology (ASCP) 2020 Annual Meeting, taking pla
